Harvest Management’s St Jude Medical STJ Stock Holding History

Harvest Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-169,449	Closed	-$13.6M	–	100
2016 Q4	$13.6M	Buy	169,449 +107,149	+172%	+$8.5M	7.89%	1
2016 Q3	$4.97M	Sell	62,300 -3,000	-5%	-$242K	3.93%	6
2016 Q2	$5.09M	Buy	+65,300	New	+$4.66M	3.85%	6

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Harvest Management's STJ Position: Q1 2017 in Review

Harvest Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 169,449 shares — an estimated $13.6M sold.

Harvest Management first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $13.6M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Harvest Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Harvest Management sold 169,449 St Jude Medical shares in Q1 2017, an estimated $13.6M.
Harvest Management first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
Harvest Management's St Jude Medical position peaked at $13.6M in Q4 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Harvest Management's 13F filing for Q1 2017, filed 11 May 2017.